In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Vicor's current price exceeds the PERT-weighted fair value by 21.2%, indicating potential overvaluation. Strong financial health contrasts sharply with weak growth, while Monte Carlo outcomes reveal significant downside risk and low expected value near $2.75. Analyst targets diverge markedly from fundamental valuations, reflecting high uncertainty.